학술논문
Anxiety and behavioral changes in Japanese patients with inflammatory bowel disease due to COVID-19 pandemic: a national survey.
Document Type
Academic Journal
Author
Nakase H; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan. hiropynakase@gmail.com.; Wagatsuma K; Department of Gastroenterology and Hepatology, Sapporo Medical University School of Medicine, S-1, W-16, Chuo-Ku, Sapporo, Hokkaido, 060-8543, Japan.; Nojima M; Center for Translational Research, The Institute of Medical Science, The University of Tokyo, Minato-Ku, Japan.; Matsumoto T; Division of Gastroenterology, Department of Internal Medicine, Iwate Medical University, Shiwa, Japan.; Matsuura M; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Mitaka, Japan.; Iijima H; Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine, Suita, Japan.; Matsuoka K; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Toho University Sakura Medical Center, Sakura, Japan.; Ohmiya N; Departments of Gastroenterology and Advanced Endoscopy, Fujita Health University School of Medicine, Toyoake, Japan.; Ishihara S; Department of Internal Medicine II, Faculty of Medicine, Shimane University, Izumo, Japan.; Hirai F; Department of Gastroenterology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.; Takeuchi K; Department of Gastroenterology, IBD Center, Tsujinaka Hospital Kashiwanoha, Kashiwa, Japan.; Tamura S; First Department of Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.; Kinjo F; Center for Gastroenterology, Urasoe General Hospital, Urasoe, Japan.; Ueno N; Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Japan.; Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.; Naganuma M; The Third Department of Internal Medicine, Kansai Medical University Hirakata, Hirakata, Japan.; Watanabe K; Center for Inflammatory Bowel Disease, Division of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.; Moroi R; Division of Gastroenterology, Tohoku University Hospital, Sendai, Japan.; Nishimata N; Department of Gastroenterology, Sameshima Hospital, Kagoshima, Japan.; Motoya S; IBD Center, Sapporo Kosei General Hospital, Sapporo, Japan.; Kurahara K; Division of Gastroenterology, Matsuyama Red Cross Hospital, Matsuyama, Japan.; Takahashi S; Department of Gastroenterology, Kagawa Prefectural Central Hospital, Takamatsu, Japan.; Maemoto A; Inflammatory Bowel Disease Center, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.; Sakuraba H; Department of Gastroenterology and Hematology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.; Saruta M; Department of Gastroenterology and Hepatology, Division of Internal Medicine, The Jikei University School of Medicine, Minato-Ku, Japan.; Tominaga K; Department of Gastroenterology, Dokkyo Medical University, Shimotsuga, Japan.; Hisabe T; Department of Gastroenterology, Fukuoka University Chikushi Hospital, Chikushino, Japan.; Tanaka H; Sapporo IBD Clinic, Sapporo, Japan.; Terai S; Division of Gastroenterology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.; Hiraoka S; Department of Gastroenterology and Hepatology, Dentistry and Pharmaceutical Sciences, Okayama University Graduate School of Medicine, Okayama, Japan.; Takedomi H; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Saga University, Saga, Japan.; Narimatsu K; Department of Internal Medicine, National Defense Medical College, Tokorozawa, Japan.; Endo K; Division of Gastroenterology, Tohoku Medical and Pharmaceutical University, Sendai, Japan.; Nakamura M; Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.; Hisamatsu T; Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Mitaka, Japan.
Source
Publisher: Springer International Country of Publication: Japan NLM ID: 9430794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-5922 (Electronic) Linking ISSN: 09441174 NLM ISO Abbreviation: J Gastroenterol Subsets: MEDLINE
Subject
Language
English
Abstract
Background: Given the increasing health concerns for patients with inflammatory bowel disease (IBD), amidst the COVID-19 pandemic, we investigated the impact of the pandemic on the anxiety and behavioral changes in Japanese patients with IBD.
Methods: We analyzed 3032 questionnaires from patients with IBD, aged 16 years or older visiting 30 hospitals and 1 clinic between March 2020 and June 2021. The primary outcome was the score of the anxiety experienced by patients with IBD during the pandemic.
Results: Participants reported a median age of 44 years; 43.3% of the patients were women. Moreover, 60.6% and 39.4% were diagnosed with ulcerative colitis and Crohn's disease, respectively, with a median disease duration of 10 years. Participants indicated an average of disease-related anxiety score of 5.1 ± 2.5 on a ten-point scale, with a tendency to increase, 1 month after the number of infected persons per population increased. The top three causes for anxiety were the risk of contracting COVID-19 during hospital visits, SARS-CoV-2 infection due to IBD, and infection by IBD medication. Factors associated with anxiety were gender (women), being a homemaker, hospital visit timings, mode of transportation (train), use of immunosuppressive drugs, and nutritional therapy. Most patients continued attending their scheduled hospital visits, taking their medications, experienced the need for a family doctor, and sought guidance and information regarding COVID-19 from primary doctors, television, and Internet news.
Conclusions: Patients with IBD experienced moderate disease-related anxiety due to the pandemic and should be proactively informed about infectious diseases to relieve their anxiety.
(© 2023. The Author(s).)
Methods: We analyzed 3032 questionnaires from patients with IBD, aged 16 years or older visiting 30 hospitals and 1 clinic between March 2020 and June 2021. The primary outcome was the score of the anxiety experienced by patients with IBD during the pandemic.
Results: Participants reported a median age of 44 years; 43.3% of the patients were women. Moreover, 60.6% and 39.4% were diagnosed with ulcerative colitis and Crohn's disease, respectively, with a median disease duration of 10 years. Participants indicated an average of disease-related anxiety score of 5.1 ± 2.5 on a ten-point scale, with a tendency to increase, 1 month after the number of infected persons per population increased. The top three causes for anxiety were the risk of contracting COVID-19 during hospital visits, SARS-CoV-2 infection due to IBD, and infection by IBD medication. Factors associated with anxiety were gender (women), being a homemaker, hospital visit timings, mode of transportation (train), use of immunosuppressive drugs, and nutritional therapy. Most patients continued attending their scheduled hospital visits, taking their medications, experienced the need for a family doctor, and sought guidance and information regarding COVID-19 from primary doctors, television, and Internet news.
Conclusions: Patients with IBD experienced moderate disease-related anxiety due to the pandemic and should be proactively informed about infectious diseases to relieve their anxiety.
(© 2023. The Author(s).)